Cyrus Jilla

Colt Group SA engages in the provision of connectivity products and services. Its services include managed networking and bandwidth services. The company was founded in 1992 and is headquartered in Luxembourg.

Colt Technology Services Group Ltd. provides networking, professional and information technology services. It offers optical network services, business internet and VPN, ethernet, voice, cloud and data center, cybersecurity, and wireless backhaul services. The company was founded in 1992 and is headquartered in London, the United Kingdom.

Bellefontaine Investments AG engages in the provision of real estate, retail, private equity investments, and financial services. The firm develops and manages a portfolio of retail properties. It also offers financial services from private label cards to personal loans, insurance, and savings. The company was founded in 2001 and is headquartered in Zug, Switzerland.

Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland.

Waypoint Capital Holdings (Jersey) Ltd. operates as a holding company. The company is headquartered in St. Helier, Jersey.

Volta Trucks AB is a full-electric goods vehicle manufacturer and services company that is revolutionizing urban deliveries with electric vehicles. The company is based in Stockholm, SE, and has offices in the UK. The Swedish company has partnered with leaders in the supply chain for the development and production of the Volta Zero, a wide range of top-quality electric trucks. Volta Trucks is committed to sustainable cities and has innovative and reliable safety features to ensure a secure and smooth driving experience. It was founded in 2017 by Kjell Waloen and Carl Magnus Norden, and Essa Khalid Essa Al-Saleh has been the CEO of the company since 2020.

Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA.